NFKB1 and neoplasm: A number of mechanisms can be at play to cause increased sensitivities of tumor cells to chemotherapy or radiotherapy, including inhibition of NF-κB [48], downregulation of transporters of the MDR family [49] or the Akt-mTOR pathway [50], [51], [52].